Back to discover
Drug
Racemethionine
Research stageEmerging research
Also known as (+-)-Methionine, Cotameth, DL-Methionine, DL-Methioninum+3 more
(+-)-Methionine, Cotameth, DL-Methionine, DL-Methioninum, Methionine, Pedameth, metionina.
1
Research papers
Latest activity
betaRecent clinical, regulatory, research and industry developments relating to this drug.
Research2023-08-03Nature metabolism
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Canonical name
Racemethionine
Aliases & brands
(+-)-MethionineCotamethDL-MethionineDL-MethioninumMethioninePedamethmetionina
RxNorm CUI
9100
ChEMBL ID
CHEMBL274119
UNII
73JWT2K6T3
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Most influential
Major research themes3
Gastrointestinal Microbiome1Hydrogen Sulfide1Neoplasms1
Journals, researchers & institutions
Top journals
- Nature metabolism1
Leading researchers
- Anantharaman K1
- Andrea Azcarate-Peril M1
- Arbeev KG1
- Garcia-Peterson LM1
- Hsiao YC1
- Ji M1
- Li JL1
- Li X1
Leading institutions
free-text, unnormalised
- Department of Microbiology and Immunology and Lineberger Comprehensive Cancer Center1
- Duke University School of Medicine1
- Epigenetics and Stem Cell Biology Laboratory1
- Gillings School of Global Public Health1
- National Institute of Environmental Health Sciences1
- Signal Transduction Laboratory1
Related drugs
Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).
Studied across the same disease area as Racemethionine in the shared literature.
1 shared disease1 shared paper
References & data sources
- RxNorm (U.S. National Library of Medicine) — drug identity
- ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
- Europe PMC — research literature